Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population

Published:2010-01-27 Issue:6 Volume:40 Page:508-512
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Ishitobi M.,Goranova T. E.,Komoike Y.,Motomura K.,Koyama H.,Glas A. M.,van Lienen E.,Inaji H.,Van't Veer L. J.,Kato K.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/40/6/508/5115663/hyp195.pdf

Reference15 articles.

1. Cancer Incidence and Incidence Rates in Japan in 2001 based on the Data from 10 Population-based Cancer Registries

2. Differences in Breast Cancer Between Japan and the United States 2

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

4. Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer

5. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer;Breast Cancer;2023-10-09

2. Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method;BMC Cancer;2023-07-31

3. A retrospective validation of CanAssist Breast in European early-stage breast cancer patient cohort;The Breast;2022-06

4. Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer;Cancer Management and Research;2022-02

5. Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India;South Asian Journal of Cancer;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3